Research has long supported the position that consumption of omega-3 fatty acids are good for your heart health. Omega-3 is found primarily in fish and consuming it regularly (at least twice a week) is known lower high blood pressure, slow down the plaque formation process that clogs up the arteries, lower triglyceride levels, and lessen the risk of developing arrhythmias (which may lead to a sudden heart attack and death). I myself pop-a-top twice a week on a little can of tuna (okay, so it’s not the tastiest fish on the market but it is fish!), and on days when fish isn’t in the eating equation, I dutifully swallow the recommended horse pills, excuse me, I guess that’s actually fish pills, of omega-3 fish oil. It’s seems a small, and relatively easy, thing to do in order to give my heart a healthier chance.
Omega-3 fish oil – it’s a good thing! Eat a little fish here and there, take a few omega-3 supplements, and your heart should be in good shape. Right? Wrong! New research which has recently been released seems to contradict conventional wisdom on the usage of omega-3, at least for some subsets of people.
One recent University of Pittsburgh Graduate School of Public Health study challenged the current accepted belief that omega-3 consumption reduces the risk of heart disease for everyone. According to study findings, omega-3 did not appear to help our sisters with type 1 diabetes lower their risk of heart disease. The results were surprising, particularly in light of the fact that the findings were limited to women with type 1 diabetes - men with type 1 diabetes did not share the same result.
Persons with diabetes are at a much greater risk for developing heart disease than the general population. In order to better protect the heart health of diabetics, it only makes sense that we should know and understand as much as possible about how the disease may affect a diabetic’s heart health or impact treatment options for heart disease. Long-term in nature, the Pittsburgh Epidemiology of Diabetes Complications Study began in 1986 to examine the complications arising from diabetes which first presented in the formative childhood years.